We are pleased to confirm an agreement with Italian biobanking service provider BioRep (https://www.biorep.it/en/) to provide Inaphaea's high throughput drug screening services and patient derived cells to BioRep's network of clients. 

  

The agreement with BioRep expands our reach into Europe whilst providing backup storage and molecular biology services. 

  

Mark Eccleston, Director of Inaphaea BioLabs comments: "BioRep is an excellent partner as we look to offer our PDC product line into European markets. Their expertise in sample management, characterisation capabilities and access to a broad client base as well as logistics are a great fit for Inaphaea."